Taiko Pharmaceutical Co Ltd 4574
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥407.00
- Day Range
- ¥395.00–403.00
- 52-Week Range
- ¥263.00–495.00
- Bid/Ask
- ¥396.00 / ¥397.00
- Market Cap
- ¥19.98 Bil
- Volume/Avg
- 76,800 / 223,370
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 223
- Website
- http://www.seirogan.co.jp
Comparables
Valuation
|
Metric
|
4574
|
4554
|
002864
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 11.14 | 24.67 |
Price/Book Value | 2.53 | 0.71 | 1.75 |
Price/Sales | 3.12 | 0.70 | 2.86 |
Price/Cash Flow | — | 4.37 | 16.80 |
Price/Earnings
4574
4554
002864
Financial Strength
|
Metric
|
4574
|
4554
|
002864
|
|---|---|---|---|
Quick Ratio | 2.86 | 0.55 | 3.66 |
Current Ratio | 3.61 | 1.24 | 3.89 |
Interest Coverage | −296.25 | 58.74 | 27.93 |
Quick Ratio
4574
4554
002864
Profitability
|
Metric
|
4574
|
4554
|
002864
|
|---|---|---|---|
Return on Assets (Normalized) | −1.48% | 4.98% | 5.20% |
Return on Equity (Normalized) | −2.55% | 10.16% | 7.55% |
Return on Invested Capital (Normalized) | −2.08% | 6.17% | 5.71% |
Return on Assets
4574
4554
002864
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tfpslyxx | Gqbm | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Npvldmppmb | Zwvxmk | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Nvcnymfzf | Rqgpw | $48.4 Bil | |||
| Viatris Inc
VTRS
| Glxtbqhk | Wssd | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Cpgbqvftt | Jsr | $13.5 Bil | |||
| Catalent Inc
CTLT
| Zzkrzkf | Bxxwqh | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Crnrcyvdk | Pgfljfn | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Fmzzrjzqj | Sybf | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Vwjddbffpr | Tglyk | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Gqmnnlzt | Lgfy | $2.3 Bil |
United States